Author

Dirk Schmidt‐Arras

University of SalzburgORCID 0000-0002-1072-7495Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1

Frequent Co-Authors

Birgit Halwachs· 2 shared Freia KrauseiD· 2 shared Stefan Rose‐JohniD· 2 shared Anke Senftleben· 1 shared Birte Wöhner· 1 shared Christoph SchrammiD· 1 shared Clara John· 1 shared Dorothee SchwingeiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Birgit Halwachs

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A non-catalytic function of a disintegrin and metalloprotease 10 determines hepatic progenitor cell fate

Birte Wöhner, Miryam Müller, Michael A. Pearen, Julia Köhn‐Gaone, Luise Gorki, Rebecca Philippsen, Jully Gogoi-Tiwari, Clara John, Ludger Scheja, Freia Krause, Birgit Halwachs, Roja Barikbin, Dorothee Schwinge, Stefan Rose‐John, Paul Säftig, , Dirk Schmidt‐Arras

This study shows that ADAM10's non-catalytic function, not its enzymatic activity, regulates hepatic progenitor cell fate and liver regeneration.

bioRxiv · Aug 14, 2024 · PreprintCell Biology

ADAM17 regulates hepatic DNA damage repair and tumour formation

Manuel Reichert, Birgit Halwachs, Julia Bolik, Anke Senftleben, Freia Krause, Luisa Conrady, Renate Bauer, Jacob Rachmilewitz, Jutta Horejs‐Hoeck, Stefan Rose‐John, Dirk Schmidt‐Arras

This study shows ADAM17 on myeloid cells drives hepatic DNA damage repair and tumour formation in HCC, suggesting it as a therapeutic target.

bioRxiv · Jul 30, 2024 · PreprintCancer Biology